ADAM17 anticorps (C-Term)
Aperçu rapide pour ADAM17 anticorps (C-Term) (ABIN207356)
Antigène
Voir toutes ADAM17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Synthetic peptide corresponding to C-terminal residues of human cSVP(snake venom-like protease)
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human ADAM17.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
Autre désignation
- ADAM17 / TACE
-
Sujet
-
Name/Gene ID: ADAM17
Subfamily: Metallopeptidase M12B
Family: Protease
Synonyms: ADAM17, CD156B, CD156b antigen, CSVP, ADAM 17, NISBD, TNF-alpha converting enzyme, TNF-alpha convertase, TNF-alpha-converting enzyme, Snake venom-like protease, TACE -
ID gène
- 6868
-
UniProt
- P78536
-
Pathways
- Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Antigène
-